
Chronix Biomedical
Molecular diagnostics company developing blood tests for monitoring minimal residual disease in cancer patients.
Employees
Enterprise value
$7m
Authorizing premium user...
Molecular diagnostics company developing blood tests for monitoring minimal residual disease in cancer patients.